PBM

Patient Blood Management

Strategies to optimize blood use and reduce unnecessary transfusion exposures.

PBM organises care around the patient and preservation of their blood. Its three pillars come from human medicine; veterinary application must consider species and available evidence.

01

Investigate and treat anaemia

Identify causes, monitor trends and correct diagnosed deficiencies.

  • Investigate the cause and course of anemia.
  • Correct deficiencies only when diagnosed.
  • Plan testing and blood availability before elective procedures.
02

Reduce losses

Plan haemostasis, limit unnecessary sampling and anticipate perioperative bleeding.

  • Plan hemostasis before procedures.
  • Reduce laboratory sampling volume and unnecessary repeats.
  • Track blood loss and control its source.
03

Individualise decisions

Assess perfusion, clinical signs, comorbidities and response to supportive measures.

  • Consider perfusion, comorbidities and clinical signs.
  • Document the transfusion goal and reassessment plan.
  • Reassess the response before prescribing further units.

When to consider transfusion?

Haematocrit alone does not decide. Consider trends, cause of anaemia, bleeding, circulatory stability and signs of inadequate oxygen delivery. PBM must not delay a necessary transfusion.

PBM goals in practice

Planning

Anticipate needs and document decisions.

Careful use

Track product use and wastage.

Continuity

Reassess the patient and document adverse events.

Care goals, not a promise of reduced mortality in dogs and cats.

From principles to practice

Planning examples adapted to veterinary practice; the three pillars originate in human medicine and do not define universal animal transfusion thresholds.

Before an elective procedure

Investigate anemia and bleeding history in advance. Record necessary tests, anticipated risk and compatible product availability.

During hospitalization

Plan laboratory sampling frequency and volume, avoid unnecessary repeats and track losses. Control the source of bleeding and reassess hemostasis.

When deciding to transfuse

Consider impaired oxygen delivery, anemia progression and comorbidities. Define the goal and reassessment; hematocrit alone does not decide treatment.

Track process quality

  • Documented indication and goal
  • Recorded compatibility and traceability
  • Volume used and discarded
  • Clinical response and reported reactions

Frequently asked questions

Does PBM mean avoiding every transfusion?

No. It means selecting appropriate care and reducing unnecessary exposure.

Is there a mandatory haematocrit threshold?

No single value replaces individual clinical assessment.

Is iron appropriate for every anaemia?

No. Investigate the cause before choosing treatment.

How can a practice start?

Standardise assessment, record the rationale and review response and adverse events.

Educational use: product selection, volume and rate require individual veterinary assessment. Follow your service protocol and supplier instructions.

Keep exploring